V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330008468 | 330005255 | 1.67 | 67.9 | Curative (C) | 2014-02-01 | 2014-02-01 | CISPLATIN + ETOPOSIDE | 01 | N | 330018645 | CISPLATIN + DOXORUBICIN |
| 330008469 | 330005257 | 1.78 | 11.8 | Palliative (P) | 2016-05-31 | 2016-08-28 | CAV | N | N | 330018665 | TEMOZOLOMIDE |
| 330008470 | 330005257 | null | 11.8 | Curative (C) | null | 2014-07-05 | Trabectedin | N | null | 330018665 | TRABECTEDIN |
| 330008471 | 330008869 | 1.58 | null | null | 2013-08-31 | 2013-11-16 | GEMCARBO | 02 | N | 330018684 | GEMCARBO |
| 330008472 | 330008869 | 1.7 | 96.4 | Disease modification (D) | null | 2017-04-26 | Cisplatin + Doxorubicin | 2 | N | 330018684 | AZACITIDINE |
| 330008473 | 330005261 | 1.48 | 53.5 | Neo-adjuvant (N) | 2012-10-02 | 2013-12-04 | Azacitidine | N | N | 330018705 | DA |
| 330008474 | 330011886 | 1.89 | null | Neo-adjuvant (N) | 2014-10-16 | 2014-10-16 | VAC | 2 | N | 330018707 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330008475 | 330011886 | 1.57 | 64.75 | Curative (C) | null | 2018-09-11 | Temozolomide 150mg/m2 | N | N | 330018707 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330008476 | 330005263 | 1.84 | 61 | Palliative (P) | 2017-05-17 | 2017-05-24 | CISPLATIN + ETOPOSIDE | 2 | N | 330018720 | NIVOLUMAB |
| 330008477 | 330005263 | 1.46 | 82.9 | Palliative (P) | 2016-01-04 | 2016-01-12 | GemCarbo Days 1+8 | 2 | N | 330018720 | GEMCARBO |
| 330008479 | 330008872 | null | 78.6 | Palliative (P) | 2015-01-09 | 2015-02-08 | VAC | null | Y | 330018739 | CISPLATIN + DOXORUBICIN |
| 330008480 | 330005265 | 1.63 | 61 | Neo-adjuvant (N) | 2017-01-16 | 2017-01-17 | Cisplatin + Doxorubicin | N | N | 330018763 | VINBLASTINE |
| 330008481 | 330005266 | 1.8 | 82 | Palliative (P) | 2016-09-08 | 2016-09-15 | CNS Low Grade Glioma Vinblastine | N | N | 330018777 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330008482 | 330005271 | 1.63 | 68.6 | Palliative (P) | 2015-09-04 | 2015-09-05 | EW EuroEwing 99 : VActI | 02 | N | 330018790 | EURO-EWING |
| 330008483 | 330005272 | 1.62 | 91.2 | Palliative (P) | 2013-02-27 | 2013-03-20 | GemCarbo Days 1+8 | 02 | N | 330018820 | GEMCARBO |
| 330008484 | 330005273 | 1.59 | 100 | Palliative (P) | 2016-07-18 | 2016-07-30 | NIVOLUMAB | N | N | 330018824 | CAV |
| 330008485 | 330005274 | 1.85 | 53 | Palliative (P) | 2014-10-05 | 2014-11-20 | EW EuroEwing 99 : VIDE | N | N | 330018828 | EURO-EWING |
| 330008486 | 330005275 | 1.9 | 60 | Curative (C) | 2015-10-03 | 2015-12-15 | CYCLOPHOSPHAMIDE + RITUXIMAB | 02 | N | 330018828 | DA |
| 330008487 | 330005275 | 0 | null | Palliative (P) | null | 2013-09-03 | Liposomal Doxorubicin (Caelyx) | 2 | N | 330018828 | LIPOSOMAL DOXORUBICIN |
| 330008488 | 330005279 | 0 | 79.3 | Curative (C) | 2016-02-18 | 2016-03-18 | CNS Low Grade Glioma Vinblastine | N | N | 330018883 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330008489 | 330008876 | 1.81 | 82.8 | Palliative (P) | 2015-10-21 | 2015-10-28 | CARBOPLATIN + GEMCITABINE | Y | N | 330018883 | GEMCARBO |
| 330008491 | 330005281 | 1.78 | 64 | Disease modification (D) | 2014-04-18 | 2014-04-20 | EW EuroEwing 99 : VActI | 2 | N | 330018906 | EURO-EWING |
| 330008492 | 330005284 | 1.75 | 56.7 | Palliative (P) | 2015-11-12 | 2015-11-19 | Cisplatin + Etoposide po&iv 3 day | N | N | 330018923 | AZACITIDINE |
| 330008493 | 330005286 | 1.61 | 42 | Palliative (P) | 2014-01-25 | 2014-10-03 | GemCarbo Days 1+8 | 02 | N | 330018943 | GEMCARBO |
| 330008494 | 330005287 | 0 | 84.6 | Curative (C) | 2017-07-06 | 2017-07-06 | FLAG + Idarubicin | N | N | 330018945 | FLAG + IDARUBICIN |
| 330008495 | 330005289 | 1.62 | 55.8 | Palliative (P) | 2017-06-13 | 2018-03-26 | Methotrexate intrathecal | 02 | N | 330018949 | METHOTREXATE INTRATHECAL |
| 330008496 | 330005289 | 1.76 | 44.3 | Adjuvant (A) | 2015-05-12 | 2015-05-12 | EURO-EWING | 2 | N | 330018949 | EURO-EWING |
| 330008497 | 330005290 | 1.66 | 49.4 | Curative (C) | 2018-08-21 | 2018-08-23 | Methotrexate intrathecal | N | N | 330018956 | METHOTREXATE INTRATHECAL |
| 330008498 | 330005291 | 1.86 | 77.3 | Disease modification (D) | 2015-09-03 | 2015-09-18 | GemCarbo Days 1+8 | 1 | null | 330018990 | GEMCARBO |
| 330008499 | 330005295 | 1.55 | 61.8 | Palliative (P) | 2016-10-01 | 2016-10-26 | Docetaxel 75mg/m2 (21 day) | 2 | N | 330019009 | DOCETAXEL |
| 330008500 | 330008883 | 1.55 | 87.8 | Palliative (P) | 2017-10-03 | 2017-10-10 | CNS HGG Temozolomide maintenance | N | N | 330019013 | NIVOLUMAB |
| 330008501 | 330010815 | 1.67 | 87.5 | Palliative (P) | 2018-06-19 | 2018-06-19 | GemCarbo Days 1+8 | N | null | 330019033 | GEMCARBO |
| 330008502 | 330010815 | 1.5 | 90.2 | Adjuvant (A) | 2014-12-07 | 2014-12-14 | AML Int Guide HD Cytarabine (3 + 4) | N | Y | 330019033 | CYTARABINE HIGH DOSE |
| 330008503 | 330010815 | 0 | 67.8 | Palliative (P) | 2015-04-29 | 2015-05-06 | GemCarbo Days 1+8 | N | N | 330019033 | GEMCARBO |
| 330008504 | 330005296 | 1.5 | 84 | Palliative (P) | 2017-02-19 | 2017-02-21 | DA | N | N | 330019061 | CAV |
| 330008505 | 330005297 | null | 7.7 | Palliative (P) | null | 2017-08-26 | Docetaxel | null | N | 330019079 | DOCETAXEL |
| 330008506 | 330005300 | 1.6 | 0 | Curative (C) | 2014-10-24 | 2015-04-04 | CNS Low Grade Glioma Vinblastine | 2 | Y | 330019090 | AZACITIDINE |
| 330008507 | 330005301 | 0 | 25.4 | Curative (C) | 2013-08-06 | 2013-08-07 | CAV | N | N | 330019100 | DA |
| 330008508 | 330008888 | 1.77 | 92.4 | Adjuvant (A) | null | 2015-05-11 | Cisplatin + Doxorubicin | null | null | 330019112 | VINBLASTINE |
| 330008509 | 330005304 | 0 | 88.45 | Palliative (P) | 2016-09-30 | 2016-10-07 | Methotrexate intrathecal | N | N | 330019119 | METHOTREXATE INTRATHECAL |
| 330008510 | 330005305 | 1.85 | 65.7 | Disease modification (D) | 2015-08-26 | 2015-09-01 | Cisplatin + Doxorubicin | N | N | 330019124 | CISPLATIN + DOXORUBICIN |
| 330008511 | 330005307 | 1.58 | 49 | Palliative (P) | 2015-11-12 | 2015-12-21 | EW Rel rEECur Irinotecan/Temozolomide | N | N | 330019124 | IRINOTECAN + TEMOZOLOMIDE |
| 330008512 | 330005307 | 1.95 | null | Palliative (P) | 2013-03-12 | 2013-09-02 | Etoposide oral | N | N | 330019124 | ETOPOSIDE |
| 330008513 | 330005308 | 1.6 | 90.2 | Palliative (P) | 2013-12-12 | 2013-12-20 | NIVOLUMAB | N | N | 330019273 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330008514 | 330005308 | 1.6 | 64.6 | Palliative (P) | 2016-09-12 | 2016-09-19 | Cisplatin + Etoposide po&iv 3 day | 02 | N | 330019273 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330008515 | 330005309 | 1.77 | 87.1 | Curative (C) | 2017-09-17 | 2017-09-17 | NIVOLUMAB | 2 | N | 330019291 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330008516 | 330008892 | 1.85 | 91.8 | null | 2017-07-29 | 2017-07-31 | Etoposide oral | 02 | N | 330019327 | ETOPOSIDE |
| 330008517 | 330005311 | 1.86 | 79.8 | Disease modification (D) | 2017-01-14 | 2017-01-14 | Cisplatin + Doxorubicin | 02 | N | 330019327 | AZACITIDINE |
| 330008518 | 330008894 | 1.84 | 87.1 | Curative (C) | 2017-05-07 | 2017-05-17 | Cytarabine High Dose | 02 | N | 330019347 | CYTARABINE HIGH DOSE |
| 330008519 | 330011890 | 1.67 | 49.2 | Palliative (P) | 2014-12-23 | 2015-01-04 | GemCarbo Days 1+8 | 02 | N | 330019369 | GEMCARBO |